COVID-19 PRECAUTIONS:    VIEW THE practices Arizona Oncology has implemented to protect our patients and their families.
Blog     Careers     About Us     Bill Pay     Patient Portal     QOPI Re-Certification     

Michael Durando, MD, PhD Michael Durando, MD, PhD

Michael Durando, MD, PhD

Medical Oncology and Hematology


Glendale - Saguaro Cancer Center

Glendale - Saguaro Cancer Center

7200 W. Bell Rd., Bldg. A
Glendale, AZ 85308
View Map
Call: 623-487-4822
Fax: 623-334-9881

Education & Credentials


University of Arizona

Medical School

University of North Carolina at Chapel Hill School of Medicine


Emory University School of Medicine


University of Arizona College of Medicine


Hematology/Oncology Research Track – University of Arizona Cancer Center

Board Certification

Internal Medicine

Academic Honors & Professional Achievements

University of Pennsylvania T32 Fellowship
Ruth L. Kirschstein NRSA Fellowship




  1. Michael Durando, Sanjay Menghani, Jessica Baumann, Danny Robles, Tovah Day, Cyrus Vaziri, Aaron Scott. Four-Year Disease-Free Remission in a Patient With POLE Mutation-Associated Colorectal Cancer Treated Using Anti-PD-1 Therapy. J Natl Compr Canc Netw. 2022 Mar; 20(3): 218-223
  2. Marcelo G. Kazanietz, Michael Durando, and Mariana Cooke. CXCL13 and Its Receptor CXCR5 in Cancer: Inflammation, Immune Response, and Beyond. Front Endocrinol. 2019 Jul 12; 10:471.
  3. Yang Yang, Yanzhe Gao, Liz Mutter-Rottmayer, Anastasia Zlatanou, Michael Durando, Weimin Ding, David Wyatt, Dale Ramsden, Yuki Tanoue, Satoshi Tateishi, Cyrus Vaziri. DNA repair factor RAD18 and DNA polymerase Polκ confer tolerance of oncogenic DNA replication stress. J Cell Biol. 2017 Oct 2;216(10):3097-3115.
  4. Michael Durando, Hannah Tiu, James Soo Kim. Sulfasalazine-Induced Crystalluria Causing Severe Acute Kidney Injury. Am J Kidney Dis. pii: S0272-6386(17)30748-5, 2017.
  5. Michael Durando, Satoshi Tateishi, and Cyrus Vaziri. A non-catalytic role of DNA polymerase η in recruiting Rad18 and promoting PCNA monoubiquitination at stalled replication forks. Nucleic Acids Research. 41, 3079, 2013.
  6. Yang Yang, Michael Durando, Stephanie L. Smith-Roe, Chris Sproul, Alicia Greenwalt, William Kaufmann, Sehyun Oh, Eric A. Hendrickson, and Cyrus Vaziri. Cell cycle stage-specific roles of Rad18 in tolerance and repair of oxidative DNA damage. Nucleic Acids Research. 41, 2296, 2013.
  7. Laura R. Barkley*, Komaraiah Palle*, Michael Durando*, Tovah Day, Aditi Gurkar, Naoko Kakusho, Jianying Li, Hisao Masai, and Cyrus Vaziri. c-Jun N-terminal kinase–mediated Rad18 phosphorylation facilitates Polη recruitment to stalled replication forks. Molecular Biology of the Cell, 10, 1943, 2012. (*contributed equal efforts to manuscript)
  8. Michael Durando, Rachel Morrish, and Anthony J. Muscat. Kinetics and Mechanism for the Reaction of Hexafluoroacetylacetone with CuO in Supercritical Carbon Dioxide. JACS, 130, 16659, 2008.


Michael Durando, MD, PhD, earned his medical degree from the University of North Carolina at Chapel Hill School of Medicine before completing his internship in internal medicine at Emory University School of Medicine and his residency in internal medicine at the University of Arizona College of Medicine. He completed a post-doctoral research fellowship at the University of Pennsylvania School of Medicine and a clinical fellowship at the University of Arizona Cancer Center.

Dr. Durando has considerable research experience and has been published in several medical publications, including the Journal of the National Comprehensive Cancer Network, Frontiers in Endocrinology, and the Journal of Cell Biology. In recent years, he has presented for the University of Arizona Department of Hematology/Oncology Scientific Grand Rounds. Dr. Durando is board certified in internal medicine.


AZ Oncology

Subscribe to the latest in cancer news — delivered to your inbox.